| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13659* | 2021 |
| International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide AJ Harmar, A Arimura, I Gozes, L Journot, M Laburthe, JR Pisegna, ... Pharmacological reviews 50 (2), 265-270, 1998 | 874 | 1998 |
| Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR review 1 AJ Harmar, J Fahrenkrug, I Gozes, M Laburthe, V May, JR Pisegna, ... British journal of pharmacology 166 (1), 4-17, 2012 | 522 | 2012 |
| Complete sequence of a novel protein containing a femtomolar‐activity‐dependent neuroprotective peptide M Bassan, R Zamostiano, A Davidson, A Pinhasov, E Giladi, O Perl, ... Journal of neurochemistry 72 (3), 1283-1293, 1999 | 448 | 1999 |
| Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos P Gressens, JM Hill, I Gozes, M Fridkin, DE Brenneman Nature 362 (6416), 155-158, 1993 | 344 | 1993 |
| A femtomolar-acting neuroprotective peptide. DE Brenneman, I Gozes The Journal of clinical investigation 97 (10), 2299-2307, 1996 | 318 | 1996 |
| Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial AL Boxer, AE Lang, M Grossman, DS Knopman, BL Miller, LS Schneider, ... The Lancet Neurology 13 (7), 676-685, 2014 | 310 | 2014 |
| VIP: molecular biology and neurobiological function I Gozes, DE Brenneman Molecular neurobiology 3, 201-236, 1989 | 297 | 1989 |
| Cancer-associated stroke: pathophysiology, detection and management E Dardiotis, AM Aloizou, S Markoula, V Siokas, K Tsarouhas, ... International journal of oncology 54 (3), 779-796, 2019 | 290 | 2019 |
| Cytokine regulation of neuronal survival DE Brenneman, M Schultzberg, T Bartfai, I Gozes Journal of neurochemistry 58 (2), 454-460, 1992 | 282 | 1992 |
| A glia-derived signal regulating neuronal differentiation O Blondel, C Collin, WJ McCarran, S Zhu, R Zamostiano, I Gozes, ... Journal of Neuroscience 20 (21), 8012-8020, 2000 | 275 | 2000 |
| Cloning and characterization of the human activity-dependent neuroprotective protein R Zamostiano, A Pinhasov, E Gelber, RA Steingart, E Seroussi, E Giladi, ... Journal of Biological Chemistry 276 (1), 708-714, 2001 | 269 | 2001 |
| A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice L Beni-Adani, I Gozes, Y Cohen, Y Assaf, RA Steingart, DE Brenneman, ... Journal of Pharmacology and Experimental Therapeutics 296 (1), 57-63, 2001 | 267 | 2001 |
| A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease Y Matsuoka, Y Jouroukhin, AJ Gray, L Ma, C Hirata-Fukae, HF Li, L Feng, ... Journal of Pharmacology and Experimental Therapeutics 325 (1), 146-153, 2008 | 262 | 2008 |
| Activity-dependent neuroprotective protein: a novel gene essential for brain formation A Pinhasov, S Mandel, A Torchinsky, E Giladi, Z Pittel, AM Goldsweig, ... Developmental Brain Research 144 (1), 83-90, 2003 | 254 | 2003 |
| Tubulin microheterogeneity increases with rat brain maturation I Gozes, UZ Littauer Nature 276 (5686), 411-413, 1978 | 248 | 1978 |
| Neuroprotective strategy for Alzheimer disease: intranasal administration of a fatty neuropeptide. I Gozes, A Bardea, A Reshef, R Zamostiano, S Zhukovsky, S Rubinraut, ... Proceedings of the National Academy of Sciences 93 (1), 427-432, 1996 | 246 | 1996 |
| Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model I Vulih-Shultzman, A Pinhasov, S Mandel, N Grigoriadis, O Touloumi, ... Journal of Pharmacology and Experimental Therapeutics 323 (2), 438-449, 2007 | 230 | 2007 |
| Autophagy has a key role in the pathophysiology of schizophrenia A Merenlender-Wagner, A Malishkevich, Z Shemer, M Udawela, ... Molecular psychiatry 20 (1), 126-132, 2015 | 219 | 2015 |
| Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. P Gressens, S Marret, JM Hill, DE Brenneman, I Gozes, M Fridkin, ... The Journal of clinical investigation 100 (2), 390-397, 1997 | 209 | 1997 |
Albert PinhasovAriel UniversityVerified email at ariel.ac.il
